US 12,114,998 B2
Monitoring and communicating information using drug administration devices
Frederick E. Shelton, IV, Hillsboro, OH (US); Monica A. Kapil, San Jose, CA (US); Emma L. Hubert, San Jose, CA (US); and Jason L. Harris, Lebanon, OH (US)
Assigned to Janssen Pharmaceuticals, Inc., Titusville, NJ (US)
Filed by Janssen Pharmaceuticals, Inc., Titusville, NJ (US)
Filed on Apr. 2, 2021, as Appl. No. 17/221,107.
Application 17/221,107 is a continuation of application No. 17/068,865, filed on Oct. 13, 2020.
Claims priority of provisional application 63/020,940, filed on May 6, 2020.
Claims priority of provisional application 63/020,925, filed on May 6, 2020.
Claims priority of provisional application 63/020,928, filed on May 6, 2020.
Prior Publication US 2021/0345954 A1, Nov. 11, 2021
Int. Cl. A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/11 (2006.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01); A61M 5/20 (2006.01); A61M 15/00 (2006.01); A61M 15/08 (2006.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 70/40 (2018.01); H04W 12/02 (2009.01); H04W 12/0431 (2021.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01)
CPC A61B 5/4839 (2013.01) [A61B 5/0022 (2013.01); A61B 5/02055 (2013.01); A61B 5/1101 (2013.01); A61B 5/1112 (2013.01); A61B 5/1118 (2013.01); A61B 5/14532 (2013.01); A61B 5/14542 (2013.01); A61B 5/4266 (2013.01); A61B 5/4866 (2013.01); A61M 5/1723 (2013.01); A61M 5/2033 (2013.01); A61M 15/0065 (2013.01); A61M 15/08 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 70/40 (2018.01); H04W 12/02 (2013.01); H04W 12/0431 (2021.01); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 2560/0242 (2013.01); A61M 2205/3317 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2230/04 (2013.01); A61M 2230/20 (2013.01); A61M 2230/201 (2013.01); A61M 2230/50 (2013.01); A61M 2230/63 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A medical system, comprising:
a plurality of sensors each associated with a different patient and each configured to sense information relating to a condition of the sensor's associated patient;
a plurality of drug administration devices that are each configured to deliver a drug therefrom, each of the drug administration devices being associated with a different patient among a plurality of patients; and
a server configured to wirelessly receive and aggregate the sensed information and to analyze the aggregated information so as to generate, from the sensed information associated with the plurality of patients, a clinical treatment suggestion for a one of the plurality of patients, the clinical treatment suggestion including at least one of a suggested adjusted use of the drug administration device associated with the one of the plurality of patients, a suggested elimination of use of the drug administration device associated with the one of the plurality of patients, and a suggested elimination of use of the drug for the one of the plurality of patients.